ATE520031T1 - Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogen - Google Patents
Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogenInfo
- Publication number
- ATE520031T1 ATE520031T1 AT02784318T AT02784318T ATE520031T1 AT E520031 T1 ATE520031 T1 AT E520031T1 AT 02784318 T AT02784318 T AT 02784318T AT 02784318 T AT02784318 T AT 02784318T AT E520031 T1 ATE520031 T1 AT E520031T1
- Authority
- AT
- Austria
- Prior art keywords
- breast cancer
- ibc
- invasive
- aplified
- oncogen
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34315401P | 2001-10-26 | 2001-10-26 | |
| US35630102P | 2002-02-12 | 2002-02-12 | |
| PCT/US2002/034499 WO2003035848A1 (en) | 2001-10-26 | 2002-10-28 | Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE520031T1 true ATE520031T1 (de) | 2011-08-15 |
Family
ID=26993355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02784318T ATE520031T1 (de) | 2001-10-26 | 2002-10-28 | Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1438388B1 (de) |
| JP (1) | JP2005511552A (de) |
| AT (1) | ATE520031T1 (de) |
| AU (1) | AU2002348101A1 (de) |
| CA (1) | CA2464700C (de) |
| WO (1) | WO2003035848A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0624687D0 (en) * | 2006-12-11 | 2007-01-17 | Univ Aston | Treatment of cachexia |
| US8691954B2 (en) * | 2007-02-16 | 2014-04-08 | Jin-pyo Lee | Antibody to placental protein having a regulating action on proteolytic activity |
| WO2012009577A2 (en) | 2010-07-14 | 2012-01-19 | Alper Biotech, Llc | Monoclonal antibodies against pcbp-1 antigens, and uses therefor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834192A (en) * | 1996-04-05 | 1998-11-10 | Incyte Pharmaceuticals, Inc. | Human cachexia associated protein |
| AU4199597A (en) * | 1996-09-09 | 1998-04-02 | Novo Nordisk A/S | A cdna and peptide with relation to cancer and weight loss |
-
2002
- 2002-10-28 EP EP20020784318 patent/EP1438388B1/de not_active Expired - Lifetime
- 2002-10-28 WO PCT/US2002/034499 patent/WO2003035848A1/en not_active Ceased
- 2002-10-28 JP JP2003538349A patent/JP2005511552A/ja active Pending
- 2002-10-28 AU AU2002348101A patent/AU2002348101A1/en not_active Abandoned
- 2002-10-28 AT AT02784318T patent/ATE520031T1/de not_active IP Right Cessation
- 2002-10-28 CA CA 2464700 patent/CA2464700C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1438388A4 (de) | 2005-11-23 |
| WO2003035848A9 (en) | 2005-01-20 |
| EP1438388B1 (de) | 2011-08-10 |
| EP1438388A1 (de) | 2004-07-21 |
| AU2002348101A1 (en) | 2003-05-06 |
| JP2005511552A (ja) | 2005-04-28 |
| CA2464700C (en) | 2013-12-10 |
| WO2003035848A1 (en) | 2003-05-01 |
| CA2464700A1 (en) | 2003-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE419516T1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
| PH12015501744B1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
| ATE470723T1 (de) | Genexpressionsmarker für die prognose von brustkrebs | |
| DK1565489T3 (da) | Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet | |
| WO2007016548A3 (en) | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer | |
| TW200528117A (en) | Methods and reagents for the treatment of proliferative diseases | |
| WO2003029421A3 (en) | Regulated breast cancer genes | |
| DK0991421T3 (da) | Påvisning og modulering af IAP'er og NAIP i forbindelse med diagnose og behandling af proliferativ sygdom | |
| WO2003087831A3 (en) | Proteins involved in breast cancer | |
| WO2004067570A3 (en) | Prostate cancer diagnosis and treatment | |
| IN2014DN05011A (de) | ||
| WO2004098377A3 (en) | Methods and compositions for diagnosis and therapy of parkin-associated disorders | |
| WO2003065006A3 (en) | Methods and compositions for treating cancer | |
| BRPI0414513A (pt) | kid3 e anticorpos de kid3 que se ligam a ele | |
| WO2004021010A3 (en) | Method of diagnosing colon and gastric cancers | |
| AU3392901A (en) | Proteins | |
| WO2004031414A3 (en) | Method for diagnosing prostate cancer | |
| WO2002077176A3 (en) | Aberrantly expressed proteins in laser capture microdissected tumors | |
| WO2003030725A3 (en) | Pancreatic cancer diagnosis and therapies | |
| WO2003044485A3 (en) | Proteonomic methods for diagnosis and monitoring of breast cancer | |
| WO2004040312A3 (fr) | Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie | |
| AU2002367317A1 (en) | Psoriasin expression by breast epithelial cells | |
| ATE520031T1 (de) | Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogen | |
| WO2005019475A3 (en) | Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc) | |
| EP1107006A4 (de) | Verfahren zur diagnose von knochenmetastasen und malignen tumoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |